A detailed history of Ameritas Investment Partners, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 14,886 shares of RGEN stock, worth $1.86 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,886
Previous 11,053 34.68%
Holding current value
$1.86 Million
Previous $1.39 Million 59.01%
% of portfolio
0.07%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $459,155 - $641,452
3,833 Added 34.68%
14,886 $2.22 Million
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $49,440 - $75,375
-412 Reduced 3.59%
11,053 $1.39 Million
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $18,723 - $30,397
-164 Reduced 1.41%
11,465 $2.06 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $180,691 - $229,816
-1,302 Reduced 10.07%
11,629 $1.85 Million
Q2 2023

Aug 11, 2023

SELL
$138.42 - $180.31 $29,760 - $38,766
-215 Reduced 1.64%
12,931 $1.83 Million
Q1 2023

May 10, 2023

SELL
$154.26 - $198.1 $33,628 - $43,185
-218 Reduced 1.63%
13,146 $2.21 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $14,942 - $20,291
92 Added 0.69%
13,364 $2.26 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $76,359 - $121,955
-476 Reduced 3.46%
13,272 $2.48 Million
Q4 2021

Feb 11, 2022

BUY
$247.59 - $304.47 $50,508 - $62,111
204 Added 1.51%
13,748 $3.64 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $50,055 - $83,321
-257 Reduced 1.86%
13,544 $3.91 Million
Q2 2021

Aug 06, 2021

SELL
$165.87 - $220.95 $36,325 - $48,388
-219 Reduced 1.56%
13,801 $2.76 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $19,840 - $24,888
110 Added 0.79%
14,020 $2.73 Million
Q4 2020

Feb 12, 2021

BUY
$148.08 - $206.57 $12,882 - $17,971
87 Added 0.63%
13,910 $2.67 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $24,992 - $32,287
204 Added 1.5%
13,823 $2.04 Million
Q2 2020

Aug 05, 2020

SELL
$94.33 - $140.48 $381,564 - $568,241
-4,045 Reduced 22.9%
13,619 $1.68 Million
Q1 2020

May 13, 2020

BUY
$84.96 - $109.14 $2,378 - $3,055
28 Added 0.16%
17,664 $1.71 Million
Q4 2019

Feb 13, 2020

BUY
$73.84 - $93.08 $16,170 - $20,384
219 Added 1.26%
17,636 $1.63 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $1.02 Million - $1.28 Million
13,362 Added 329.52%
17,417 $1.34 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $46,341 - $73,487
855 Added 26.72%
4,055 $349,000
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $9,238 - $11,053
284 Added 9.74%
3,200 $116,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,916
2,916 $121,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.